# Clinical Evaluation of Fenugreek Seed Extract, a Nutraceutical in Patients With Type- 2 Diabetes

> **NCT02693392** · NA · COMPLETED · sponsor: **All India Institute of Medical Sciences, Bhubaneswar** · enrollment: 200 (actual)

## Conditions studied

- Type-2 Diabetes Mellitus

## Interventions

- **DRUG:** Oral hypoglycemic agents (pre-specified) [Metformin, Sulfonylurea]
- **DIETARY_SUPPLEMENT:** Fenugreek Seed extract

## Key facts

- **NCT ID:** NCT02693392
- **Lead sponsor:** All India Institute of Medical Sciences, Bhubaneswar
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-17
- **Primary completion:** 2018-04-30
- **Final completion:** 2018-08-16
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2018-08-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02693392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02693392, "Clinical Evaluation of Fenugreek Seed Extract, a Nutraceutical in Patients With Type- 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02693392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
